索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]赵宇昊,赵蕾,杨新春.心外膜脂肪组织参与心血管疾病发生的机制[J].国际心血管病杂志,2020,06:331.
点击复制

心外膜脂肪组织参与心血管疾病发生的机制(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2020年06期
页码:
331
栏目:
综述
出版日期:
2020-12-15

文章信息/Info

Title:
-
作者:
赵宇昊; 赵蕾; 杨新春
100020 首都医科大学附属北京朝阳医院心脏中心
Author(s):
-
关键词:
心外膜脂肪组织;  冠状动脉粥样硬化性心脏病;  心房颤动;  心力衰竭;  高血压
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2020.06.004
文献标识码:
A
摘要:
心外膜脂肪组织(EAT)位于心肌和心包膜脏层之间,具有独特的解剖特性和生理特性,可以通过旁分泌及自分泌的方式调控冠状动脉及心肌组织的生理功能。该文介绍EAT在心血管疾病发病过程中的重要作用。
Abstract:
-

参考文献/References

[1] Sacks HS, Fain JN. Human epicardial adipose tissue: a review[J]. Am Heart J, 2007, 153(6):907-917.
[2] Patel VB, Shah S, Verma S, et al. Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease[J]. Heart Fail Rev, 2017, 22(6):889-902.
[3] Chechi K, Voisine P, Mathieu P, et al. Functional characterization of the Ucp1-associated oxidative phenotype of human epicardial adipose tissue[J]. Sci Rep, 2017, 7(1):15566.
[4] Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography:anew method for visceral adipose tissue prediction[J]. Obes Res, 2003, 11(2):304-310.
[5] Davidovich D, Gastaldelli A, Sicari R. Imaging cardiac fat[J]. Eur Heart J Cardiovasc Imaging, 2013, 14(7):625-630.
[6] Bertaso AG, Bertol D, Duncan BB, et al. Epicardial fat: definition, measurements and systematic review of main outcomes[J]. Arq Bras Cardiol, 2013, 101(1):e18-e28.
[7] Tran T, Small G, Cocker M, et al. A single slice measure of epicardial adipose tissue can serve as an indirect measure of total epicardial adipose tissue burden and is associated with obstructive coronary artery disease[J]. Eur Heart J Cardiovasc Imaging, 2014, 15(4):423-430.
[8] Le Jemtel TH, Samson R, Ayinapudi K, et al. Epicardial adipose tissue and cardiovascular disease[J]. Curr Hypertens Rep, 2019, 21(5):36.
[9] Djaberi R, Schuijf JD, van Werkhoven JM, et al. Relation of epicardial adipose tissue to coronary atherosclerosis[J]. Am J Cardiol, 2008, 102(12):1602-1607.
[10] Salazar J, Luzardo E, Mejías JC, et al. Epicardial fat: physiological, pathological, and therapeutic implications[J]. Cardiol Res Pract, 2016:1291537.
[11] Alam MS, Green R, de Kemp R, et al. Epicardial adipose tissue thickness as a predictor of impaired microvascular function in patients with non-obstructive coronary artery disease[J]. J Nucl Cardiol, 2013, 20(5):804-812.
[12] Miksztowicz V, Morales C, Barchuk M, et al. Metalloproteinase 2 and 9 activity increase in epicardial adipose tissue of patients with coronary artery disease[J]. Curr Vasc Pharmacol, 2017, 15(2):135-143.
[13] Castoldi A, Naffah de Souza C, Camara NO,et al. The macrophage switch in obesity development[J]. Front Immunol, 2015, 6:637.
[14] Goeller M, Achenbach S, Marwan M, et al. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects[J]. J Cardiovasc Comput Tomogr, 2018, 12(1):67-73.
[15] Oka T, Yamamoto H, Ohashi N, et al. Association between epicardial adipose tissue volume and characteristics of non-calcified plaques assessed by coronary computed tomographic angiography[J]. Int J Cardiol, 2012, 161(1):45-49.
[16] Nappi C, Ponsiglione A, Acampa W, et al. Relationship between epicardial adipose tissue and coronary vascular function in patients with suspected coronary artery disease and normal myocardial perfusion imaging[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(12):1379-1387.
[17] Gohbara M, Iwahashi N, Akiyama E, et al. Association between epicardial adipose tissue volume and myocardial salvage in patients with a first ST-segment elevation myocardial infarction: an epicardial adipose tissue paradox[J]. J Cardiol, 2016, 68(5):399-405.
[18] Al Chekakie MO, Welles CC, Metoyer R, et al. Pericardial fat is independently associated with human atrial fibrillation[J]. J Am Coll Cardiol, 2010, 56(10):784-788.
[19] Chao TF, Hung CL, Tsao HM, et al. Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation[J]. PLoS One, 2013, 8(9):e74926.
[20] Haemers P, Hamdi H, Guedj K, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria[J]. Eur Heart J, 2017, 38(1):53-61.
[21] Venteclef N, Guglielmi V, Balse E, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines[J]. Eur Heart J, 2015, 36(13):795-805.
[22] Abe I, Teshima Y, Kondo H, et al. Association of fibrotic remodeling and cytokineschemokines content in epicardialadipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation[J].Heart Rhythm, 2018, 15(11):1717-1727.
[23] Suffee N, Moore-Morris T, Farahmand P, et al. Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria[J]. Proc Natl Acad Sci U S A, 2017, 114(5):E771-E780.
[24] van Rosendael AR, Dimitriu-Leen AC, van Rosendael PJ, et al. Association between posterior left atrial adipose tissue mass and atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2017, 10(2):004614
[25] Chu C, Lee W, Hsu P, et al. Association of increased epicardial adipose tissue thickness with adverse cardiovascular outcomes in patients with atrial fibrillation[J]. Medicine, 2016, 95(11):e2874.
[26] van Woerden G, Gorter TM, Westenbrink BD, et al. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction[J]. Eur J Heart Fail, 2018, 20(11):1559-1566.
[27] Wu CK, Tsai HY, Su MM,et al. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients[J]. J Clin Lipidol, 2017, 11(6):1421-1431.
[28] White IA. Cardiac sympathetic denervation in the failing hearta role for epicardial adipose tissue[J]. Circ Res, 2016, 118(8):1189-1191.
[29] Parisi V, Rengo G, Perrone-Filardi P, et al. Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure[J]. Circ Res, 2016, 118(8):1244-1253.
[30] Agra RM, Teijeira-Fernández E, Pascual-Figal D, et al. Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients[J]. Eur J Clin Invest, 2014, 44(1):29-37.
[31] Zhao L, Guo Z, Wang P, et al. Proteomics of epicardial adipose tissue in patients with heart failure[J]. J Cell Mol Med, 2020, 24(1):511-520.
[32] Yang Y, Liu S, Zhang R, et al. Association between C1q/TNF-related protein-1 levels in human plasma and epicardial adipose tissues and congestive heart failure[J]. Cell Physiol Biochem, 2017, 42(5):2130-2143.
[33] Austys D, Dobrovolskij A, Jablonskienè V, et al. Epicardial adipose tissue accumulation and essential hypertension in non-obese adults[J]. Medicina(Kaunas), 2019, 55(8):456.
[34] Erdogan G, Belen E, Sungur M A, et al. Assessment of epicardial adipose tissue thickness in patients with resistant hypertension[J]. Blood Press Monit, 2016, 21(1):16-20.
[35] Teijeira-Fernandez E, Eiras S, Grigorian-Shamagian L, et al. Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension[J]. J Hum Hypertens, 2008, 22(12):856-863.
[36] Derya MA, Demir V, Ede H. Relationship between neutrophil/lymphocyte ratio and epicardial fat tissue thickness in patients with newly diagnosed hypertension[J]. J Int Med Res, 2018, 46(3):940-950.
[37] 刁盈盈, 吕迁洲, 杨昌生, 等. 高血压患者血清人软骨糖蛋白水平变化及其与内皮功能的相关性研究[J]. 中华心血管病杂志, 2013, 41(2):121-125.
[38] BakirciV EM, Degirmenci H, Hamur H, et al. New inflammatory markers for prediction of non-dipper blood pressure pattern in patients with essential hypertension: Serum YKL-40/Chitinase 3-like protein 1 levels and echocardiographic epicardial adipose tissue thickness[J]. Clin Exp Hypertens, 2015, 37(6):505-510.

备注/Memo

备注/Memo:
通信作者:杨新春,E-mail:yangxinchun6229@163.com
更新日期/Last Update: 2020-12-15